ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1031

Expanded Circulating Peripheral Helper T Cells Are Associated with B Cell Differentiation in Systemic Lupus Erythematosus

Ayako Makiyama1, Asako Chiba 2, Daisuke Noto 1, Goh Murayama 3, Tomohiro Mizuno 4, Taiga Kuga 5, Ken Yamaji 5, Naoto Tamura 5 and Sachiko Miyake 2, 1Juntendo University School of Medicine, Tokyo, Japan, 2Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan, 3Department of Internal Medicine and Rhumatology, Juntendo University School of Medicine, Tokyo, Japan, 4Department of Immunlogy, Juntendo University School of Medicine, Tokyo, Japan, 5Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Plasmablasts and tertiary, Systemic lupus erythematosus (SLE), T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: SLE – Etiology & Pathogenesis Poster I

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Autoreactive T-B cell interactions in lymphoid tissue have been thought to play a crucial role in the autoantibody production in systemic lupus erythematosus (SLE). These CD4+T cells are known as follicular helper T (TFH) cells expressing CXCR5, a chemokine receptor promoting cell migration to B cell follicles. Recently, a new population of ‘peripheral helper’ T (TPH) cells that help B cell responses has been discovered in synovium of patients with rheumatoid arthritis. Like TFH cells, TPH cells express ICOS and PD-1, but these cells lack CXCR5. Previously we reported that circulating TPH cells are increased in SLE and their activated status was associated with the disease activity. Here we assessed whether TPH cells contribute to autoantibody production by B cells in SLE.

Methods: Peripheral blood mononuclear cells collected from SLE patients and healthy individuals were analyzed for T and B cell subsets by flow cytometry. TPH cells were identified as CD3+CD4+CD45RA–CXCR5– cells with a high expression of PD-1. The production of IL-21 by TPH cells stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin was assessed by intracellular cytokine staining and flow cytometry. To assess functional roles of TPH cells in B cell maturation and antibody production, T cell populations (TPH, TFH, and CXCR5–PD-1–memory CD4+T cells)and switched memory B (CD19+CD27+IgD–) cells were sorted from PBMC using magnetic bead selection and a FACS Aria sorter. Sorted T cell populations and autologous B cells were co-cultured and stimulated with lipopolysaccharide (LPS) and staphylococcus enterotoxin B (SEB) for 7 days. Plasmablast differentiation was assessed by flow cytometry. Antibody levels in culture supernatants were measured by ELISA.

Results: Activated TPH cells were positively correlated with SLEDAI and anti-DNA antibody titers, and were negatively correlated with serum complement levels and lymphocyte counts.  The frequency of activated TPH cells was correlated with that of plasmablasts and activated switched memory B cells. Lupus TPH cells had the capacity to produce IL-21, a pivotal cytokine for B cell and plasma cell differentiation, as much as TFH cells. TPH cells from lupus patients induced B cell differentiation into plasmablasts and promoted antibody production in T-B cell co-cultures.

Conclusion: Our data demonstrate that the increased frequency and activated status of TPH cells are associated with the disease activity as well as enhanced B cell responses in SLE, and TPH cells provide B cell help. CD4+ICOS+PD-1+cells and plasma cells were reported to be present in the nephritic kidneys and associated with active disease in SLE. These data indicate the contribution of TPH cells to autoantibody production in aberrant lymphoid organs and the involvement of extra-follicular T-B cell interactions in the pathogenesis of SLE.


Disclosure: A. Makiyama, None; A. Chiba, None; D. Noto, None; G. Murayama, None; T. Mizuno, None; T. Kuga, None; K. Yamaji, ASAHI KASEI PHARMA, 2, Astellas pharma, 2, 8, bristol myers, 8, Chugai Pharma, 2, Janssen Pharma, 8, Mitsubishi-Tanabe Pharma, 2, 8, Sanofi Pharma, 8, Takeda Pharma, 2; N. Tamura, AbbVie GK, 8, AbbVie pharma, 8, ASAHI KASEI MEDICAL, 2, ASAHI KASEI PHARMA, 2, astellas pharma, 2, 8, Astellas Pharma Inc., 2, 8, AYUMI PHARMA, 2, AYUMI Pharmaceutical Corporation, 2, bristol myers, 8, Bristol-Myers Squibb, 8, Chugai Phamaceutical Co. Ltd., 2, Chugai Pharma, 2, Eisai Co., Ltd., 2, Eisai Pharama, 2, Janssen Pharma, 8, Janssen Pharmaceutical K.K., 8, Mitsubishi Tanabe Pharma Corporation, 2, 8, Mitsubishi-Tanabe Pharma, 2, 8, Sanofi K.K., 8, Sanofi Pharma, 8, Takeda Pharma, 2, Takeda Pharmaceutical Company Ltd., 2; S. Miyake, Bristol myers squibb, 2, Bristol-Myers Squibb, 2, Pfizer, 2, Pfizer Japan Inc., 2, Taiho pharmaceutical, 8, TAIHO PHARMACEUTICAL CO., LTD., 8.

To cite this abstract in AMA style:

Makiyama A, Chiba A, Noto D, Murayama G, Mizuno T, Kuga T, Yamaji K, Tamura N, Miyake S. Expanded Circulating Peripheral Helper T Cells Are Associated with B Cell Differentiation in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/expanded-circulating-peripheral-helper-t-cells-are-associated-with-b-cell-differentiation-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expanded-circulating-peripheral-helper-t-cells-are-associated-with-b-cell-differentiation-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology